Global Stock Valuation

CO
 Stock
  

USD 2.99  0.77  34.68%   

What is the current enterprise value of Global Cord Blood? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Global Cord, is its stock price multiplied by the total number of shares outstanding, calculating Global Cord's enterprise value requires a different approach. It uses Global Cord's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Global Cord Blood retains a regular Real Value of $3.84 per share. The prevalent price of the firm is $2.99. Based on Macroaxis valuation methodology, the firm appears to be undervalued. Our model calculates the value of Global Cord Blood from evaluating the firm fundamentals such as Return On Equity of 10.82 %, current valuation of (529.94 M), and Return On Asset of 0.0463 % as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage picking up undervalued assets and discarding overvalued assets since, at some point, asset prices and their ongoing real values will come together.
  
Global Cord Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Global Cord's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Global Most Recent Valuation Data

Beta
(0.0421) 
Fiscal Year End
March
property Plant And Equipment Net
476.7 M
Enterprise Value
-529.9 M
current Deferred Revenue
458.3 M
net Debt
-6.7 B
Undervalued
Today 2.99
Please note that Global Cord's price fluctuation is unstable at this time. Calculation of the real value of Global Cord Blood is based on 3 months time horizon. Increasing Global Cord's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Global Cord Blood is useful when determining the fair value of the Global stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Global Cord. Since Global Cord is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Global Stock. However, Global Cord's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
3.84
Real Value
8.43
Upside
Estimating the potential upside or downside of Global Cord Blood helps investors to forecast how Global stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Global Cord more accurately as focusing exclusively on Global Cord's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimated ValueHigh
0.163.287.87
Details
1 Analysts
Consensus
LowTarget PriceHigh
6.506.506.50
Details

Global Cord Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Global Cord's current stock value. Our valuation model uses many indicators to compare Global Cord value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Global Cord competition to find correlations between indicators driving Global Cord's intrinsic value. More Info.
Global Cord Blood is number one stock in price to book category among related companies. It is number one stock in beta category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Global Cord by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Global Cord's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Global Cord's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Global Cord's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Global Cord and how it compares across the competition.

About Global Cord Valuation

The stock valuation mechanism determines the current worth of Global Cord Blood on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Global Cord Blood. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Global Cord Blood based exclusively on its fundamental and basic technical indicators. By analyzing Global Cord's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Global Cord's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Global Cord. We calculate exposure to Global Cord's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Global Cord's related companies.
Fiscal Year End
March
Industry
Diagnostics & Research
Concentration
Health Care Services
Full Time Employees
1.2 K
Service Category
Health Care Providers & Services
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the Peoples Republic of China. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd. Global Cord operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 1202 people.

Global Cord Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Global Cord does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
DescriptionGlobal Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the Peoples Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers and tests, processes, and stores donated cord blood, as well as
Quarterly Earnings Growth Y O Y-0.182
Continue to Trending Equities. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for analysis

When running Global Cord Blood price analysis, check to measure Global Cord's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Cord is operating at the current time. Most of Global Cord's value examination focuses on studying past and present price action to predict the probability of Global Cord's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Global Cord's price. Additionally, you may evaluate how the addition of Global Cord to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Is Global Cord's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Global Cord. If investors know Global will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Global Cord listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
(0.18) 
Market Capitalization
404 M
Quarterly Revenue Growth YOY
(0.017) 
Return On Assets
0.0463
Return On Equity
10.82
The market value of Global Cord Blood is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global Cord's value that differs from its market value or its book value, called intrinsic value, which is Global Cord's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global Cord's market value can be influenced by many factors that don't directly affect Global Cord's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Global Cord's value and its price as these two are different measures arrived at by different means. Investors typically determine Global Cord value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global Cord's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.